{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:29:04Z","timestamp":1793924944498,"version":"4.8.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:00:00Z","timestamp":1793923200000},"content-version":"vor","delay-in-days":114,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China grant","award":["82503478"],"award-info":[{"award-number":["82503478"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Hebei Natural Science Foundation","award":["H2025206841"],"award-info":[{"award-number":["H2025206841"]}]},{"name":"the Hebei Province Medical Research-Enterprise Joint Innovation Special Project","award":["LH20250134"],"award-info":[{"award-number":["LH20250134"]}]},{"name":"the Hebei Province Medical Research-Enterprise Joint Innovation Special Project","award":["LH20250005"],"award-info":[{"award-number":["LH20250005"]}]},{"name":"the Hebei Provincial Medical Science Research Project Plan","award":["20260519"],"award-info":[{"award-number":["20260519"]}]},{"name":"the Hebei Provincial Government Funding Program for Outstanding Clinical Medical Talents","award":["ZF2025180"],"award-info":[{"award-number":["ZF2025180"]}]},{"name":"the Hebei Provincial Government Funding Program for Outstanding Clinical Medical Talents","award":["ZF2026215."],"award-info":[{"award-number":["ZF2026215."]}]},{"name":"the Hebei Provincial Government Funding Program for Outstanding Clinical Medical Talents","award":["ZF2025194"],"award-info":[{"award-number":["ZF2025194"]}]},{"name":"the S&T Program of Hebei grant","award":["242W7713Z"],"award-info":[{"award-number":["242W7713Z"]}]},{"name":"Province Medical Research-Enterprise Joint Innovation Special Project","award":["LH20250167"],"award-info":[{"award-number":["LH20250167"]}]},{"name":"National Natural Science Foundation of China grant","award":["82573273"],"award-info":[{"award-number":["82573273"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the S&T Program of Hebei grants","award":["23297701Z"],"award-info":[{"award-number":["23297701Z"]}]},{"name":"the Hebei Province Medical Applicable Technology Tracking Project","award":["GZ20250046"],"award-info":[{"award-number":["GZ20250046"]}]},{"name":"the Hengrui-Hebei Innovative Development Medical Cooperation Program Project","award":["HR202501001"],"award-info":[{"award-number":["HR202501001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01531-w","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:47:28Z","timestamp":1784126848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcriptomics-driven non-invasive liquid biopsy for diagnosing peritoneal lavage cytology-positive gastric cancer"],"prefix":"10.1038","volume":"10","author":[{"given":"Ping\u2019an","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongkun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1603-3002","authenticated-orcid":false,"given":"Qun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"1531_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1531_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1531_CR3","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1245\/s10434-009-0709-9","volume":"16","author":"S Gonz\u00e1lez-Moreno","year":"2009","unstructured":"Gonz\u00e1lez-Moreno, S. Peritoneal dissemination: a pending issue in gastric cancer worth exploring. Ann. Surg. Oncol. 16, 3217\u20133218 (2009).","journal-title":"Ann. Surg. Oncol."},{"key":"1531_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10120-017-0749-y","volume":"21","author":"S Jamel","year":"2018","unstructured":"Jamel, S. et al. Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis. Gastric Cancer 21, 10\u201318 (2018).","journal-title":"Gastric Cancer"},{"key":"1531_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.791912","volume":"11","author":"P Ding","year":"2022","unstructured":"Ding, P. et al. Predictive effect of systemic immune-inflammation index combined with prognostic nutrition index score on efficacy and prognosis of neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib conversion therapy in gastric cancer patients with positive peritoneal lavage cytology: a prospective study. Front. Oncol. 11, 791912 (2022).","journal-title":"Front. Oncol."},{"key":"1531_CR6","unstructured":"Brieley, J. D. G. M. & Wittekind, C. TNM Classification of Malignant Tumours 8th edn (Wiley-Blackwell, 2017)."},{"key":"1531_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10120-011-0040-6","volume":"14","author":"T Sano","year":"2011","unstructured":"Sano, T. & Aiko, T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer 14, 97\u2013100 (2011).","journal-title":"Gastric Cancer"},{"key":"1531_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10120-020-01137-6","volume":"24","author":"T Yamaguchi","year":"2021","unstructured":"Yamaguchi, T. et al. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study. Gastric Cancer 24, 701\u2013709 (2021).","journal-title":"Gastric Cancer"},{"key":"1531_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/jso.23632","volume":"110","author":"JP De Andrade","year":"2014","unstructured":"De Andrade, J. P. & Mezhir, J. J. The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review. J. Surg. Oncol. 110, 291\u2013297 (2014).","journal-title":"J. Surg. Oncol."},{"key":"1531_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1061806","volume":"12","author":"J Li","year":"2023","unstructured":"Li, J. et al. CT characteristics for predicting prognosis of gastric cancer with synchronous peritoneal metastasis. Front. Oncol. 12, 1061806 (2023).","journal-title":"Front. Oncol."},{"key":"1531_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108448","volume":"50","author":"M Mansoor","year":"2024","unstructured":"Mansoor, M., Ahmed, M. & Manzoor, I. Shaping gastric cancer outcomes: advancing diagnosis and treatment through staging laparoscopy in peritoneal metastasis detection. Eur. J. Surg. Oncol. 50, 108448 (2024).","journal-title":"Eur. J. Surg. Oncol."},{"key":"1531_CR12","doi-asserted-by":"publisher","first-page":"9275","DOI":"10.1007\/s00330-023-09854-z","volume":"33","author":"P Liu","year":"2023","unstructured":"Liu, P. et al. Prediction of occult peritoneal metastases or positive cytology using CT in gastric cancer. Eur. Radiol. 33, 9275\u20139285 (2023).","journal-title":"Eur. Radiol."},{"key":"1531_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00330-019-06368-5","volume":"30","author":"S Liu","year":"2020","unstructured":"Liu, S. et al. Radiomics analysis using contrast-enhanced CT for preoperative prediction of occult peritoneal metastasis in advanced gastric cancer. Eur. Radiol. 30, 239\u2013246 (2020).","journal-title":"Eur. Radiol."},{"key":"1531_CR14","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1245\/s10434-019-07812-y","volume":"27","author":"ZY Li","year":"2020","unstructured":"Li, Z. Y. et al. Four-point computed tomography scores for evaluation of occult peritoneal metastasis in patients with gastric cancer: a region-to-region comparison with staging laparoscopy. Ann. Surg. Oncol. 27, 1103\u20131109 (2020).","journal-title":"Ann. Surg. Oncol."},{"key":"1531_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10120-019-00994-0","volume":"23","author":"I Yasufuku","year":"2020","unstructured":"Yasufuku, I. et al. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy. Gastric Cancer 23, 319\u2013327 (2020).","journal-title":"Gastric Cancer"},{"key":"1531_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/lap.2017.0170","volume":"28","author":"J Huang","year":"2018","unstructured":"Huang, J. et al. Yield of staging laparoscopy for incurable factors in Chinese patients with advanced gastric cancer. J. Laparoendosc. Adv. Surg. Tech. A 28, 19\u201324 (2018).","journal-title":"J. Laparoendosc. Adv. Surg. Tech. A"},{"key":"1531_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-019-0220-8","volume":"13","author":"M Chen","year":"2019","unstructured":"Chen, M. & Zhao, H. Next-generation sequencing in liquid biopsy: cancer screening and early detection. Hum. Genomics 13, 34 (2019).","journal-title":"Hum. Genomics"},{"key":"1531_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05350-2","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers. Cell Death Dis. 13, 903 (2022).","journal-title":"Cell Death Dis."},{"key":"1531_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107458","volume":"207","author":"A Campos-Carrillo","year":"2020","unstructured":"Campos-Carrillo, A. et al. Circulating tumor DNA as an early cancer detection tool. Pharm. Ther. 207, 107458 (2020).","journal-title":"Pharm. Ther."},{"key":"1531_CR20","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.1158\/1078-0432.CCR-19-2774","volume":"25","author":"AM Frankell","year":"2019","unstructured":"Frankell, A. M. & Smyth, E. C. ctDNA in gastric and gastroesophageal cancer: prognostic, predictive, or preliminary?. Clin. Cancer Res. 25, 6893\u20136895 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1531_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-023-06225-y","volume":"619","author":"SA Cohen","year":"2023","unstructured":"Cohen, S. A., Liu, M. C. & Aleshin, A. Practical recommendations for using ctDNA in clinical decision making. Nature 619, 259\u2013268 (2023).","journal-title":"Nature"},{"key":"1531_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154941","volume":"132","author":"DK Dang","year":"2022","unstructured":"Dang, D. K. & Park, B. H. Circulating tumor DNA: current challenges for clinical utility. J. Clin. Invest. 132, e154941 (2022).","journal-title":"J. Clin. Invest."},{"key":"1531_CR23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/s41587-021-00857-z","volume":"39","author":"IW Deveson","year":"2021","unstructured":"Deveson, I. W. et al. SEQC2 Oncopanel Sequencing Working Group. Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nat. Biotechnol. 39, 1115\u20131128 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1531_CR24","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1158\/1078-0432.CCR-19-3231","volume":"26","author":"A Sathe","year":"2020","unstructured":"Sathe, A. et al. Single-cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment. Clin. Cancer Res. 26, 2640\u20132653 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1531_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18159","volume":"28","author":"WA Awuah","year":"2024","unstructured":"Awuah, W. A. et al. Exploring the current landscape of single-cell RNA sequencing applications in gastric cancer research. J. Cell Mol. Med. 28, e18159 (2024).","journal-title":"J. Cell Mol. Med."},{"key":"1531_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.730","volume":"12","author":"H Jiang","year":"2022","unstructured":"Jiang, H. et al. Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA Sequencing. Clin. Transl. Med. 12, e730 (2022).","journal-title":"Clin. Transl. Med."},{"key":"1531_CR27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.21037\/tcr-22-537","volume":"11","author":"H Wang","year":"2022","unstructured":"Wang, H., Jin, W., Wan, C. & Zhu, C. Diagnostic value of combined detection of CA72-4, CA19-9, and carcinoembryonic antigen comparing to CA72-4 alone in gastric cancer: a systematic review and meta-analysis. Transl. Cancer Res. 11, 848\u2013856 (2022).","journal-title":"Transl. Cancer Res."},{"key":"1531_CR28","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.21.02745","volume":"40","author":"YX Gwee","year":"2022","unstructured":"Gwee, Y. X. et al. Integration of genomic biology into therapeutic strategies of gastric cancer peritoneal metastasis. J. Clin. Oncol. 40, 2830 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1531_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1001\/jamasurg.2022.0182","volume":"157","author":"GZ Li","year":"2022","unstructured":"Li, G. Z., Doherty, G. M. & Wang, J. Surgical management of gastric cancer: a review. JAMA Surg. 157, 446\u2013454 (2022).","journal-title":"JAMA Surg."},{"key":"1531_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/annonc\/mdz001","volume":"30","author":"D Dong","year":"2019","unstructured":"Dong, D. et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann. Oncol. 30, 431\u2013438 (2019).","journal-title":"Ann. Oncol."},{"key":"1531_CR31","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.4240\/wjgs.v15.i10.2280","volume":"15","author":"SYA Ho","year":"2023","unstructured":"Ho, S. Y. A. & Tay, K. V. Systematic review of diagnostic tools for peritoneal metastasis in gastric cancer-staging laparoscopy and its alternatives. World J. Gastrointest. Surg. 15, 2280\u20132293 (2023).","journal-title":"World J. Gastrointest. Surg."},{"key":"1531_CR32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1245\/s10434-022-12399-y","volume":"30","author":"BG Sullivan","year":"2023","unstructured":"Sullivan, B. G. et al. Circulating tumor DNA is unreliable to detect somatic gene alterations in gastrointestinal peritoneal carcinomatosis. Ann. Surg. Oncol. 30, 278\u2013284 (2023).","journal-title":"Ann. Surg. Oncol."},{"key":"1531_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1245\/s10434-022-12543-8","volume":"30","author":"BG Sullivan","year":"2023","unstructured":"Sullivan, B. G., Dayyani, F. & Senthil, M. ASO author reflections: challenges of circulating tumor DNA in the management of gastrointestinal peritoneal carcinomatosis. Ann. Surg. Oncol. 30, 285\u2013286 (2023).","journal-title":"Ann. Surg. Oncol."},{"key":"1531_CR34","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41571-022-00660-y","volume":"19","author":"A Tivey","year":"2022","unstructured":"Tivey, A., Church, M., Rothwell, D., Dive, C. & Cook, N. Circulating tumour DNA\u2014looking beyond the blood. Nat. Rev. Clin. Oncol. 19, 600\u2013612 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1531_CR35","doi-asserted-by":"publisher","first-page":"e1001453","DOI":"10.1371\/journal.pmed.1001453","volume":"10","author":"L Marisa","year":"2013","unstructured":"Marisa, L. et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 10, e1001453 (2013).","journal-title":"PLoS Med."},{"key":"1531_CR36","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","volume":"39","author":"JM Chan","year":"2021","unstructured":"Chan, J. M. et al. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell 39, 1479\u20131496.e18 (2021).","journal-title":"Cancer Cell"},{"key":"1531_CR37","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1038\/s41388-019-0702-0","volume":"38","author":"K Echizen","year":"2019","unstructured":"Echizen, K. et al. NF-\u03baB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells. Oncogene 38, 4250\u20134263 (2019).","journal-title":"Oncogene"},{"key":"1531_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.radonc.2017.09.043","volume":"126","author":"Z Qiu","year":"2018","unstructured":"Qiu, Z., Oleinick, N. L. & Zhang, J. ATR\/CHK1 inhibitors and cancer therapy. Radiother. Oncol. 126, 450\u2013464 (2018).","journal-title":"Radiother. Oncol."},{"key":"1531_CR39","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/ijc.33702","volume":"149","author":"R Mu","year":"2021","unstructured":"Mu, R. et al. Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival. Int. J. Cancer 149, 1302\u20131312 (2021).","journal-title":"Int. J. Cancer"},{"key":"1531_CR40","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1158\/0008-5472.CAN-08-0884","volume":"68","author":"H Gali-Muhtasib","year":"2008","unstructured":"Gali-Muhtasib, H. et al. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Res. 68, 5609\u20135618 (2008).","journal-title":"Cancer Res."},{"key":"1531_CR41","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.chom.2023.06.016","volume":"31","author":"I Sharafutdinov","year":"2023","unstructured":"Sharafutdinov, I. et al. A single-nucleotide polymorphism in Helicobacter pylori promotes gastric cancer development. Cell Host Microbe 31, 1345\u20131358.e6 (2023).","journal-title":"Cell Host Microbe"},{"key":"1531_CR42","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1007\/s00018-013-1307-3","volume":"70","author":"M Patil","year":"2013","unstructured":"Patil, M., Pabla, N. & Dong, Z. Checkpoint kinase 1 in DNA damage response and cell cycle regulation. Cell Mol. Life Sci. 70, 4009\u20134021 (2013).","journal-title":"Cell Mol. Life Sci."},{"key":"1531_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/path.1324","volume":"200","author":"H Grabsch","year":"2003","unstructured":"Grabsch, H. et al. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer-association with tumour cell proliferation. J. Pathol. 200, 16\u201322 (2003).","journal-title":"J. Pathol."},{"key":"1531_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00535-012-0565-4","volume":"47","author":"E Oki","year":"2012","unstructured":"Oki, E. et al. Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers. J. Gastroenterol. 47, 351\u2013358 (2012).","journal-title":"J. Gastroenterol."},{"key":"1531_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.canlet.2005.06.017","volume":"237","author":"DG Hayward","year":"2006","unstructured":"Hayward, D. G. & Fry, A. M. Nek2 kinase in chromosome instability and cancer. Cancer Lett. 237, 155\u2013166 (2006).","journal-title":"Cancer Lett."},{"key":"1531_CR46","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.21037\/jtd.2017.06.91","volume":"9","author":"P Zhan","year":"2017","unstructured":"Zhan, P. et al. Protein regulator of cytokinesis-1 expression: prognostic value in lung squamous cell carcinoma patients. J. Thorac. Dis. 9, 2054\u20132060 (2017).","journal-title":"J. Thorac. Dis."},{"key":"1531_CR47","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/ars.2017.7268","volume":"30","author":"A Parascandolo","year":"2019","unstructured":"Parascandolo, A. & Laukkanen, M. O. Carcinogenesis and reactive oxygen species signaling: interaction of the NADPH oxidase NOX1-5 and superoxide dismutase 1-3 signal transduction pathways. Antioxid. Redox Signal 30, 443\u2013486 (2019).","journal-title":"Antioxid. Redox Signal"},{"key":"1531_CR48","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1074\/jbc.M109.071779","volume":"285","author":"M Shinohara","year":"2010","unstructured":"Shinohara, M. et al. Reactive oxygen generated by NADPH oxidase 1 (Nox1) contributes to cell invasion by regulating matrix metalloprotease-9 production and cell migration. J. Biol. Chem. 285, 4481\u20134488 (2010).","journal-title":"J. Biol. Chem."},{"key":"1531_CR49","doi-asserted-by":"publisher","first-page":"22164","DOI":"10.18632\/aging.203502","volume":"13","author":"L Zhi","year":"2021","unstructured":"Zhi, L. et al. SLCO1B3 promotes colorectal cancer tumorigenesis and metastasis through STAT3. Aging 13, 22164\u201322175 (2021).","journal-title":"Aging"},{"key":"1531_CR50","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.1158\/0008-5472.CAN-07-1489","volume":"67","author":"T Kokuryo","year":"2007","unstructured":"Kokuryo, T. et al. Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma. Cancer Res. 67, 9637\u20139642 (2007).","journal-title":"Cancer Res."},{"key":"1531_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani, J. A. et al. Gastric Cancer, Version 2.2022, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw. 20, 167\u2013192 (2022).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"1531_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cac2.12516","volume":"44","author":"FH Wang","year":"2024","unstructured":"Wang, F. H. et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun. 44, 127\u2013172 (2024).","journal-title":"Cancer Commun."},{"key":"1531_CR53","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick, F. et al. ESMO Guidelines Committee. Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann. Oncol. 33, 1005\u20131020 (2022).","journal-title":"Ann. Oncol."},{"key":"1531_CR54","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1038\/s41388-024-03099-w","volume":"43","author":"P Ding","year":"2024","unstructured":"Ding, P. et al. N6-methyladenosine modified circPAK2 promotes lymph node metastasis via targeting IGF2BPs\/VEGFA signaling in gastric cancer. Oncogene 43, 2548\u20132563 (2024).","journal-title":"Oncogene"},{"key":"1531_CR55","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13046-024-03098-5","volume":"43","author":"P Ding","year":"2024","unstructured":"Ding, P. et al. Transcriptomics-based liquid biopsy panel for early non-invasive identification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer. J. Exp. Clin. Cancer Res. 43, 181 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1531_CR56","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/cac2.12193","volume":"41","author":"FH Wang","year":"2021","unstructured":"Wang, F. H. et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun. 41, 747\u2013795 (2021).","journal-title":"Cancer Commun."},{"key":"1531_CR57","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s10120-018-0890-2","volume":"22","author":"K Liu","year":"2019","unstructured":"Liu, K. et al. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China. Gastric Cancer 22, 506\u2013517 (2019).","journal-title":"Gastric Cancer"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01531-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01531-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01531-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:18:28Z","timestamp":1793924308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01531-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1531"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01531-w","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"431"}}